Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd391045d8k.htm

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER & MID-YEAR 2012 RESULTS

Performance Reflects Continuing Strong Market Demand and Successful Operational Execution

Newport Beach, CA – August 2, 2012 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the second quarter and six month period ended June 30, 2012.

Fiscal 2012 Second Quarter Financial Highlights – versus Fiscal 2011 Second Quarter:

 

   

Net sales improved from $80.1 million to $84.8 million, an increase of 6%

 

   

Net income improved from $6.0 million to $8.7 million, an increase of 46%

 

   

Earnings per diluted share were $0.30 versus $0.22 in the prior year

Fiscal 2012 First Half Financial Highlights – versus Fiscal 2011 First Half

 

   

Net sales improved from $146.1 million to $172.1 million, an increase of 18%

 

   

Net income improved from $11.0 million to $17.5 million, an increase of 59%

 

   

Earnings per diluted share were $0.61 versus $0.40 in the prior year

Note: Complete details are available in the financial schedules attached to this press release

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “We are pleased to report performance for the second quarter and the first half of 2012 that reflects strong demand for our products and improved profitability of this business. This is consistent with a continued interest in our conventional chemistries as part of Integrated Pest Management. Many of our products are used at the time of planting or early in the growing season and have been relatively unaffected by the persistent drought that has affected the Midwest and Southwest United States. Our successful sales, marketing and operating efforts have driven our bottom-line, net income to just over 10% of net sales (for the quarter) and boosted gross profit margins to 45% for the quarter and 44% for the first half of 2012.”

Mr. Wintemute continued: “We continue to strengthen our already healthy balance sheet, by controlling inventory levels, carefully managing our receivable collections and reducing our long-term debt with scheduled quarterly payments. At mid-year we reported $48 million in cash on the balance sheet and stockholder’s equity of $206 million – a 10% increase during the last 6 months. We have not borrowed against our revolving-line-of-credit for over a year and have adequate cash and credit availability for working capital and other needs.”


Mr. Wintemute concluded: “We are well positioned to take advantage of favorable market conditions for the balance of the year. Factors that will affect our relative success in the third quarter include continued demand for our post-harvest Metam soil fumigants, sufficient pest pressure to support our Bidrin® foliar cotton insecticide, favorable weather conditions for cotton harvest in support of our Folex® harvest defoliant, and wet weather in regions where our mosquito adulticide, Dibrom, is used. Further, despite dry weather during the 2012 corn growing season, we continue to see strong demand for our products in anticipation of the 2013 season.”

Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 12:00 pm EDT / 9:00 am PDT on Thursday, August 2, 2012. Interested parties may participate in the call by dialing (201) 493-6744 please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes as well as the S&P Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.amvac-chemical.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

CONTACT:   -OR-      AVD’S INVESTOR RELATIONS FIRM
American Vanguard Corporation        The Equity Group Inc.
William A. Kuser, Director of Investor Relations        www.theequitygroup.com
(949) 260-1200        Lena Cati
williamk@amvac-chemical.com        Lcati@equityny.com
       mailto:(212) 836-961


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

 

     For the three months
ended June 30
    For the six months
ended June 30
 
     2012     2011     2012     2011  

Net sales

   $ 84,837      $ 80,062      $ 172,092      $ 146,095   

Cost of sales

     46,491        48,381        96,368        87,503   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     38,346        31,681        75,724        58,592   

Operating expenses

     24,104        20,998        47,080        38,722   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     14,242        10,683        28,644        19,870   

Interest expense

     721        978        1,456        1,785   

Interest capitalized

     (112     (16     (148     (74

Extinguishment of debt

     —          —          —          546   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income tax

     13,633        9,721        27,336        17,613   

Income tax expense

     4,889        3,714        9,858        6,594   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     8,744        6,007        17,478        11,019   

Change in fair value of interest rate swaps

     24        (700     46        (946

Foreign currency translation adjustment

     (420     197       122        434   
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income

   $ 8,348      $ 5,504      $ 17,646      $ 10,507   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—basic

   $ .31      $ .22      $ .63      $ .40   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ .30      $ .22      $ .61      $ .40   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—basic

     27,858        27,548        27,740        27,538   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     28,737        27,838        28,544        27,813   
  

 

 

   

 

 

   

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

ASSETS (note 7)

 

     June 30,
2012
    Dec. 31,
2011
 
     (Unaudited)     (Note)  

Current assets:

    

Cash

   $ 48,048      $ 35,085   

Receivables:

    

Trade, net of allowance for doubtful accounts of $561 and $340, respectively

     72,774        68,611   

Other

     886        1,187   
  

 

 

   

 

 

 
     73,660        69,798   
  

 

 

   

 

 

 

Inventories

     79,922        71,068   

Prepaid expenses

     4,429        2,311   

Income taxes receivable

     —          203   
  

 

 

   

 

 

 

Total current assets

     206,059        178,465   

Property, plant and equipment, net

     48,449        39,273   

Intangible assets

     113,059        116,189   

Other assets

     4,077        5,214   
  

 

 

   

 

 

 
   $ 371,644      $ 339,141   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Current installments of long-term debt

   $ 15,051      $ 14,460   

Current installments of other liabilities

     1,072        1,038   

Accounts payable

     23,837        23,214   

Deferred revenue

     201        7,571   

Accrued program costs

     57,734        25,910   

Accrued expenses and other payables

     6,143        6,832   

Income taxes payable

     30        —     
  

 

 

   

 

 

 

Total current liabilities

     104,068        79,025   

Long-term debt, excluding current installments

     41,027        51,917   

Other liabilities, excluding current installments

     5,563        5,955   

Deferred income taxes

     15,172        15,172   
  

 

 

   

 

 

 

Total liabilities

     165,830        152,069   
  

 

 

   

 

 

 

Commitments and contingent liabilities

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —          —     

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 30,158,615 shares at June 30, 2012 and 29,845,047 shares at December 31, 2011

     3,016        2,985   

Additional paid-in capital

     48,411        45,966   

Accumulated other comprehensive loss

     (2,082     (2,250

Retained earnings

     159,622        143,524   
  

 

 

   

 

 

 
     208,967        190,225   

Less treasury stock, at cost, 2,260,996 shares at June 30, 2012 and at December 31, 2011

     (3,153     (3,153
  

 

 

   

 

 

 

Total stockholders’ equity

     205,814        187,072   
  

 

 

   

 

 

 
   $ 371,644      $ 339,141   
  

 

 

   

 

 

 

Note: The balance sheet at December 31, 2011 has been derived from the audited financial statements at that date.


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For The Six Months Ended June 30, 2012 and 2011

(Unaudited)

 

Increase (decrease) in cash

   2012     2011  

Cash flows from operating activities:

    

Net income

   $ 17,478      $ 11,019   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization of fixed and intangible assets

     7,046        6,733   

Amortization of other long term assets

     1,574        1,934   

Amortization of discounted liabilities

     396        988   

Stock-based compensation

     1,031        1,031   

Tax benefit from exercise of stock options

     (160     —     

Changes in assets and liabilities associated with operations:

    

Increase in net receivables

     (3,862     (41,019

Increase in inventories

     (8,854     (6,566

Increase in prepaid expenses and other assets

     (2,555     (1,791

Decrease in income tax receivable/payable, net

     393        8,133   

Increase in accounts payable

     668        9,089   

Decrease in deferred revenue

     (7,370     (5,474

Increase in other liabilities

     30,883        18,220   
  

 

 

   

 

 

 

Net cash provided by operating activities

     36,668        2,297   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Capital expenditures

     (13,061     (2,322
  

 

 

   

 

 

 

Net cash used in investing activities

     (13,061     (2,322
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net repayments under line of credit agreement

     —          (7,300

Principal payments on long-term debt

     (4,000     (4,004

Tax benefit from exercise of stock options

     160     

Borrowings on long-term debt

     —          20,063  

Decrease in other notes payable

     (6,827     —     

Payment of cash dividends

     (1,380     (826 )

Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock option)

     1,285        550   
  

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (10,762     8,483   
  

 

 

   

 

 

 

Net increase in cash

     12,845        8,458   

Cash and cash equivalents at beginning of year

     35,085        1,158   

Effect of exchange rate changes on cash

     118        342   
  

 

 

   

 

 

 

Cash and cash equivalents as of June 30

   $ 48,048      $ 9,958